$UBS

UBS Group AG

CIK:0001610520|SEC Filings

Consolidated Income Statement - USD ($) $ in Millions	12 Months Ended
Consolidated Income Statement - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Line Items]
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income	$ 27,948	$ 35,994	$ 31,743
Interest expense from financial instruments measured at amortized cost	(26,544)	(35,947)	(28,216)
Net interest income from financial instruments measured at fair value through profit or loss and other	6,343	7,061	3,770
Net interest income	7,747	7,108	7,297
Other net income from financial instruments measured at fair value through profit or loss	14,011	14,690	11,583
Fee and commission income	30,581	28,730	23,766
Fee and commission expense	(2,669)	(2,592)	(2,195)
Net fee and commission income	27,912	26,138	21,570
Other income	(96)	675	384
Total revenues	49,573	48,611	40,834
Credit loss expense / (release)	524	551	1,037
Personnel expenses	27,861	27,318	24,899
General and administrative expenses	8,807	10,124	10,156
Depreciation, amortization and impairment of non-financial assets	3,529	3,798	3,750
Operating expenses	40,197	41,239	38,806
Operating profit / (loss) before tax	8,853	6,821	28,255
Tax expense / (benefit)	1,056	1,675	873
Net profit / (loss)	7,797	5,146	27,382
Net profit / (loss) attributable to non-controlling interests	30	60	16
Net profit / (loss) attributable to shareholders for basic EPS	$ 7,767	$ 5,085	$ 27,366
Earnings per share
Basic	$ 2.46	$ 1.59	$ 8.68
Diluted	$ 2.36	$ 1.52	$ 8.30
Credit Suisse
Income Statement [Line Items]
Negative goodwill			$ 27,264

Consolidated Statement of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flow from / (used in) operating activities
Net profit / (loss)	$ 7,797	$ 5,146	$ 27,382
Non-cash items included in net profit and other adjustments:
Depreciation, amortization and impairment of non-financial assets	3,529	3,798	3,750
Credit loss expense / (release)	524	551	1,037
Share of net (profits) / loss of associates and joint ventures and impairment related to associates	(77)	(144)	348
Deferred tax expense / (benefit)	(382)	(495)	(694)
Net loss / (gain) from investing activities	(485)	101	(102)
Net loss / (gain) from financing activities	17,866	(5,314)	8,534
Other net adjustments	(28,570)	22,379	(15,175)
Net change in operating assets and liabilities:
Amounts due from banks and amounts due to banks	(77)	(2,353)	3,291
Receivables from securities financing transactions measured at amortized cost	40,504	(23,884)	(3,503)
Payables from securities financing transactions measured at amortized cost	800	(552)	(2,014)
Cash collateral on derivative instruments	1,590	242	96
Loans and advances to customers	(16,316)	27,019	27,877
Customer deposits	(12,939)	(15,072)	52,786
Financial assets and liabilities at fair value held for trading and derivative financial instruments	25,196	(13,594)	3,674
Brokerage receivables and payables	2,928	2,179	(5,962)
Financial assets at fair value not held for trading and other financial assets and liabilities	(13,411)	5,327	9,938
Provisions and other non-financial assets and liabilities	(4,577)	(116)	3,920
Income taxes paid, net of refunds	(2,049)	(1,938)	(1,852)
Net cash flow from / (used in) operating activities	21,851	3,279	86,068
Cash flow from / (used in) investing activities
Cash and cash equivalents acquired upon the acquisition of the Credit Suisse Group	276
Purchase of subsidiaries, business, associates and intangible assets	(17)	(64)	(4)
Disposal of subsidiaries, business, associates and intangible assets	653	256	121
Purchase of property, equipment and software	(2,362)	(2,008)	(1,685)
Disposal of property, equipment and software	209	108	65
Purchase of financial assets measured at fair value	(16,717)	(4,638)	(4,157)
Disposal and redemption of financial assets measured at fair value	5,210	4,635	4,187
Purchase of debt securities measured at amortized cost	(21,569)	(5,962)	(14,244)
Disposal and redemption of debt securities measured at amortized cost	11,791	8,384	10,435
Net cash flow from / (used in) investing activities	(22,802)	709	103,124
Cash flow from / (used in) financing activities
Repayment of Swiss National Bank funding		(42,587)	(56,516)
Net issuance (repayment) of short-term debt measured at amortized cost	1,692	(7,407)	3,169
Net movements in treasury shares and own equity derivative activity	(5,178)	(2,923)	(2,779)
Distributions paid on UBS shares	(2,866)	(2,256)	(1,679)
Issuance of debt designated at fair value and long-term debt measured at amortized cost	131,476	100,145	109,735
Repayment of debt designated at fair value and long-term debt measured at amortized cost	(154,614)	(129,683)	(109,471)
Inflows from securities financing transactions measured at amortized cost	2,319	6,273
Outflows from securities financing transactions measured at amortized cost	(2,734)	(4,740)
Net cash flows from other financing activities	(959)	(987)	(721)
Net cash flow from / (used in) financing activities	(30,863)	(84,165)	(58,262)
Total cash flow
Cash and cash equivalents at the beginning of the year	244,090	340,207	195,321
Net cash flow from / (used in) operating, investing and financing activities	(31,815)	(80,176)	130,931
Effects of exchange rate differences on cash and cash equivalents	19,098	(15,940)	13,955
Cash and cash equivalents at the end of the year	231,375	244,090	340,207
of which: cash and balances at central banks	209,858	223,329	313,976
of which: amounts due from banks	18,292	17,383	19,212
of which: money market paper	3,224	3,117	7,018
Net cash flow from / (used in) operating activities includes:
Interest received in cash	42,589	53,498	44,581
Interest paid in cash	37,749	48,252	35,969
Dividends on equity investments, investment funds and associates received in cash	$ 3,204	$ 2,864	2,296
Credit Suisse
Non-cash items included in net profit and other adjustments:
Negative goodwill			(27,264)
Cash flow from / (used in) investing activities
Cash and cash equivalents acquired upon the acquisition of the Credit Suisse Group			$ 108,406

Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Assets
Cash and balances at central banks	$ 209,858	$ 223,329
Amounts due from banks	19,649	18,903
Receivables from securities financing transactions measured at amortized cost	83,656	118,301
Cash collateral receivables on derivative instruments	41,552	43,959
Loans and advances to customers	653,846	579,967
Other financial assets measured at amortized cost	71,897	58,835
Total financial assets measured at amortized cost	1,080,458	1,043,293
Financial assets at fair value held for trading	174,699	159,065
of which: assets pledged as collateral that may be sold or repledged by counterparties	44,627	38,532
Derivative financial instruments	147,778	185,551
Brokerage receivables	35,579	25,858
Financial assets at fair value not held for trading	107,575	95,472
Total financial assets measured at fair value through profit or loss	465,631	465,947
Financial assets measured at fair value through other comprehensive income	13,868	2,195
Investments in associates	2,332	2,306
Property, equipment and software	16,057	15,498
Goodwill and intangible assets	6,948	6,887
Deferred tax assets	11,525	11,134
Other non-financial assets	20,609	17,766
Total assets	1,617,427	1,565,028
Liabilities
Amounts due to banks	24,434	23,347
Payables from securities financing transactions measured at amortized cost	16,225	14,833
Cash collateral payables on derivative instruments	34,222	35,490
Customer deposits	788,367	745,777
Debt issued measured at amortized cost	214,706	214,219
Other financial liabilities measured at amortized cost	15,862	21,033
Total financial liabilities measured at amortized cost	1,093,816	1,054,698
Financial liabilities at fair value held for trading	53,700	35,247
Derivative financial instruments	156,243	180,636
Brokerage payables designated at fair value	62,202	49,023
Debt issued designated at fair value	113,794	107,909
Other financial liabilities designated at fair value	28,184	28,699
Total financial liabilities measured at fair value through profit or loss	414,123	401,514
Provisions and contingent liabilities	5,035	8,409
Other non-financial liabilities	13,970	14,834
Total liabilities	1,526,944	1,479,454
Equity
Share capital	334	346
Share premium	9,217	12,012
Treasury shares	(7,891)	(6,402)
Retained earnings	82,740	78,035
Other comprehensive income recognized directly in equity, net of tax	5,813	1,088
Equity attributable to shareholders	90,213	85,079
Equity attributable to non-controlling interests	271	494
Total equity	90,484	85,574
Total liabilities and equity	$ 1,617,427	$ 1,565,028